Potentiation of adenosine activity by low oral doses of lidoflazine.
D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D001783:Blood Flow Velocity; D003331:Coronary Vessels / Q000187:drug effects / Q000502:physiology; D004106:Dilatation; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D008297:Male; D009705:Nucleosides / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D013268:Stimulation, Chemical; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D000814:Aniline Compounds; D009705:Nucleosides; D010879:Piperazines; D014665:Vasodilator Agents